相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity
Daniel R. Ambruso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins
Wang Zhiyu et al.
CANCER BIOLOGY & THERAPY (2012)
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Paul D. Ray et al.
CELLULAR SIGNALLING (2012)
Proteomic profiling of follicular and papillary thyroid tumors
Anastasios Sofiadis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer
Hui-chan He et al.
FEBS LETTERS (2012)
Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species
Hiroaki Miki et al.
JOURNAL OF BIOCHEMISTRY (2012)
Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer
Bo Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Peroxiredoxins 3 and 4 Are Overexpressed in Prostate Cancer Tissue and Affect the Proliferation of Prostate Cancer Cells in Vitro
Ramesh Ummanni et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro
L. M. Dittmann et al.
ONCOGENE (2012)
Targeting the Androgen Receptor
Terence W. Friedlander et al.
UROLOGIC CLINICS OF NORTH AMERICA (2012)
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
Agnete Svendsen et al.
ACTA NEUROPATHOLOGICA (2011)
Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation
Mai-cang Gao et al.
ACTA PHARMACOLOGICA SINICA (2011)
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Peeter Karihtala et al.
BMC CANCER (2011)
Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells
Jhang Ho Pak et al.
CANCER INVESTIGATION (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells
Masaki Shiota et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Proteomic analysis of stage I endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation
G. Larry Maxwell et al.
GYNECOLOGIC ONCOLOGY (2011)
Peroxiredoxin II Restrains DNA Damage-induced Death in Cancer Cells by Positively Regulating JNK-dependent DNA Repair
Kyung Wha Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer
Jeong Youp Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Identification of PRDX4 and P4HA2 as Metastasis-Associated Proteins in Oral Cavity Squamous Cell Carcinoma by Comparative Tissue Proteomics of Microdissected Specimens Using iTRAQ Technology
Kai-Ping Chang et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell Carcinoma
Jintao Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2011)
The Role of Peroxiredoxin V in (-)-Epigallocatechin 3-gallate-Induced Multiple Myeloma Cell Death
Lina Ren et al.
ONCOLOGY RESEARCH (2011)
The Antioxidant Protein Peroxiredoxin 4 Is Epigenetically Down Regulated in Acute Promyelocytic Leukemia
Karishma K. Palande et al.
PLOS ONE (2011)
Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
Ebony R. Hoskins et al.
PLOS ONE (2011)
Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer
Caroline M. Woolston et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Differential Expression of Peroxiredoxins in Prostate Cancer: Consistent Upregulation of PRDX3 and PRDX4
Anamika Basu et al.
PROSTATE (2011)
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis
Marjo Pylvas et al.
EUROPEAN JOURNAL OF CANCER (2010)
Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3
Eva-Maria Hanschmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine
Hayley C. Whitaker et al.
PLOS ONE (2010)
Redox Potential and Peroxide Reactivity of Human Peroxiredoxin 3
Andrew G. Cox et al.
BIOCHEMISTRY (2009)
Peroxiredoxins, a novel target in cancer radiotherapy
Bo Zhang et al.
CANCER LETTERS (2009)
Typical 2-Cys peroxiredoxins - modulation by covalent transformations and noncovalent interactions
Martin Aran et al.
FEBS JOURNAL (2009)
Typical 2-Cys peroxiredoxins - structures, mechanisms and functions
Andrea Hall et al.
FEBS JOURNAL (2009)
Reversible oxidation of mitochondrial peroxiredoxin 3 in mouse heart subjected to ischemia and reperfusion
Vikas Kumar et al.
FEBS LETTERS (2009)
Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia
Pablo E. Vivas-Mejia et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
Mee-Kyung Cha et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Prx1 Enhances Androgen Receptor Function in Prostate Cancer Cells by Increasing Receptor Affinity to Dihydrotestosterone
Rishi Raj Chhipa et al.
MOLECULAR CANCER RESEARCH (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The Warburg Effect Suppresses Oxidative Stress Induced Apoptosis in a Yeast Model for Cancer
Christoph Ruckenstuhl et al.
PLOS ONE (2009)
Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: Mitochondrial targeted preconditioning
David W. Busija et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice
Liuji Chen et al.
AGING CELL (2008)
Redox regulation of cell survival
Dunyaporn Trachootham et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
Andrew G. Cox et al.
BIOCHEMICAL PHARMACOLOGY (2008)
BASH: a tool for managing BeadArray spatial artefacts
J. M. Cairns et al.
BIOINFORMATICS (2008)
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma
Valentina Fogal et al.
CANCER RESEARCH (2008)
Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target
Joo-Heon Kim et al.
CLINICAL CANCER RESEARCH (2008)
Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis
Andrew G. Cox et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated
Kristin K. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+
Stephanie De Simoni et al.
NEUROSCIENCE LETTERS (2008)
Alterations in β-catenin expression and localization in prostate cancer
Hayley C. Whitaker et al.
PROSTATE (2008)
Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
Jian-Feng Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Peroxiredoxin 1 interacts with androgen receptor and enhances its transactivation
Soo-Yeon Park et al.
CANCER RESEARCH (2007)
beadarray:: R classes and methods for Illumina bead-based data
Mark J. Dunning et al.
BIOINFORMATICS (2007)
Labeling and identification of LNCaP cell surface proteins: A pilot study
Hayley C. Whitaker et al.
PROSTATE (2007)
A role for neurotensin in bicalutamide resistant prostate cancer cells
Maria Vias et al.
PROSTATE (2007)
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer
Xin-Zhong Chang et al.
BREAST CANCER RESEARCH (2007)
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung
JH Park et al.
RESPIROLOGY (2006)
Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer
CY Quan et al.
JOURNAL OF UROLOGY (2006)
Mitochondrial DNA determines androgen dependence in prostate cancer cell lines
M Higuchi et al.
ONCOGENE (2006)
The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide
A Hobisch et al.
PROSTATE (2006)
Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance
V Besada et al.
PROTEOMICS (2006)
Multiple RNA surveillance pathways limit aberrant expression of iron uptake mRNAs and prevent iron toxicity in S-cerevisiae
A Lee et al.
MOLECULAR CELL (2005)
Peroxiredoxins, a novel protein family in lung cancer
ST Lehtonen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Cloning of bovine peroxiredoxins - gene expression in bovine tissues and amino acid sequence comparison with rat, mouse and primate peroxiredoxins
G Leyens et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2003)
Structure, mechanism and regulation of peroxiredoxins
ZA Wood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
The c-Myc target gene PRDX3 is required mitochondrial homeostasis and neoplastic transformation
DR Wonsey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
VL Kinnula et al.
JOURNAL OF PATHOLOGY (2002)
Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein
J Fujii et al.
REDOX REPORT (2002)
分享论文
